Advanced search
Publication Cover
Journal of Cosmetic and Laser Therapy Volume 4, 2002 - Issue 1
Submit an article Journal homepage
86
Views
60
CrossRef citations to date
0
Altmetric
Research Article

Botulinum toxins types A and B for brow furrows: preliminary experiences with type B toxin dosing

Nicholas J Lowe UCLA School of Medicine, Los Angeles, CA, USA; Clinical Research Specialists, Santa Monica, CA, USA
,
Paul S Yamauchi UCLA School of Medicine, Los Angeles, CA, USA; Research Specialists Santa Monica, CA, USA
,
Gary P Lask UCLA School of Medicine, Los Angeles, CA, USA; Research Specialists Santa Monica, CA, USA
,
Rickie Patnaik Research Specialists Santa Monica, CA, USA
&
Donna Moore Research Specialists Santa Monica, CA, USA
Pages 15-18 | Published online: 12 Jul 2009

  • Simpson LL The action of botulinal toxin. Rev Infect Dis 1979; 1:656-62.
  • Hallett M. One man's poison - clinical applications of botulinum toxin. N Engl J Med 1999; 341:118-20.
  • Blitzer A, Binder WJ, Aviv JE, Keen MS, Brin MS. The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients. Arch Otolaryngol Head Neck Surg 1997; 123:389-92.
  • Carruthers A, Carruthers J. Cosmetic uses of botulinum A exotoxin. Adv Dermatol 1997; 12:325-47; discussion 348.
  • Carruthers A, Kiene K, Carruthers J. Botulinum A exotoxin use in clinical dermatology. J Am Acad Dermatol 1996; 34: 788-97.
  • Klein AW. Cosmetic therapy with botulinum toxin, Anecdotal memoirs. Dermatol Surg 1996; 22:757-9.
  • Lowe NJ, Maxwell A, Harper H. Botulinum A exotoxin for glabellar folds: a double-blind, placebo-controlled study with an electromyographic injection technique. J Am Acad Dermatol 1996; 35: 569-72.
  • Lew MF, Brashear A, Factor S. The safety and efficacy of botulinum toxin type B in the treatment of patients with cervical dystonia: summary of three controlled clinical trials. Neurology 2000; 55 (suppl): S29-35.
  • Brashear A, Lew MF, Dykstra DD et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia. Neurology 1999; 53:1439-46.
  • Brin MF, Lew MF, Adler CH et al. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resdstant cervical dystonia. Neurology 1999; 53:1431-8.
  • Oarruthers A, Lowe NJ, Menter A. Botulinum toxin A for glabellar lines. J Am Acad Dermatol (in press).
  • Klein AW, Glogau RG. Botulinum toxin: beyond cosmesis. Aral Dermatol 2000; 136: 539-41.
  • Sloop RR, Cole BA, Escutin RO. Human response to botulinum toxin injection: type B compared with type A. Neurology 1997; 49:189-94

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.